PH22012000077U1 - A new pharmaceutical preparation for the cure of baldness - Google Patents
A new pharmaceutical preparation for the cure of baldnessInfo
- Publication number
- PH22012000077U1 PH22012000077U1 PH2/2012/000077U PH22012000077U PH22012000077U1 PH 22012000077 U1 PH22012000077 U1 PH 22012000077U1 PH 22012000077 U PH22012000077 U PH 22012000077U PH 22012000077 U1 PH22012000077 U1 PH 22012000077U1
- Authority
- PH
- Philippines
- Prior art keywords
- finasteride
- utility
- baldness
- model
- cure
- Prior art date
Links
- 201000004384 Alopecia Diseases 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 230000003676 hair loss Effects 0.000 title 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 abstract 3
- 229960004039 finasteride Drugs 0.000 abstract 3
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 206010024870 Loss of libido Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 206010068168 androgenetic alopecia Diseases 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This utility model refers to pharmaceutical preparations specifically for the treatment and prevention of male pattern baldness using finasteride as the active ingredient. Prior to this utility model, finasteride was delivered in the body through the oral route. However, this route creates side effects such as loss of libido, erectile dysfunction and decreased volume of ejaculate. This utility model describes the use of finasteride for this purpose in an acceptable topical carrier where it will be massaged directly to the affected area at a ratio ranging from 0.05 to 3.0% w/w.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH2/2012/000077U PH22012000077U1 (en) | 2012-02-14 | 2012-02-14 | A new pharmaceutical preparation for the cure of baldness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH2/2012/000077U PH22012000077U1 (en) | 2012-02-14 | 2012-02-14 | A new pharmaceutical preparation for the cure of baldness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22012000077U1 true PH22012000077U1 (en) | 2013-05-03 |
Family
ID=94240468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH2/2012/000077U PH22012000077U1 (en) | 2012-02-14 | 2012-02-14 | A new pharmaceutical preparation for the cure of baldness |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH22012000077U1 (en) |
-
2012
- 2012-02-14 PH PH2/2012/000077U patent/PH22012000077U1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01728A (en) | ||
| PH12014502516B1 (en) | Formulations and methods for vaginal delivery of antiprogestins | |
| BR112012031297A2 (en) | oral spray formulations and methods for administering sildenafil | |
| IN2015DN01727A (en) | ||
| MX347359B (en) | Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors. | |
| PH12019501016A1 (en) | Treatment of cns diseases with sgc stimulators | |
| IN2014MN02269A (en) | ||
| EA201691267A1 (en) | Nonsteroidal antigens and selective modulators of anti-gene receptors with a pyridyl group | |
| WO2014027981A3 (en) | Effervescent tablet formulations of dapoxetine and a pde5 inhibitor | |
| WO2012131341A3 (en) | Tight junctions modulators | |
| BR112015027436A2 (en) | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients | |
| MXPA06013133A (en) | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction. | |
| TN2016000121A1 (en) | Cyclic thienouracil-carboxamides and use thereof | |
| MX2015013155A (en) | Tetrandrine family pharmaceutical formulations and method. | |
| WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
| IN2014MN02156A (en) | ||
| IN2014MN01933A (en) | ||
| MX366309B (en) | Pharmaceutical composition for treating inflammation and pain. | |
| HK1209027A1 (en) | Vesicular formulations, uses and methods | |
| MX368640B (en) | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION and PAIN. | |
| GB201115977D0 (en) | Neurodevelopmental disorders | |
| UA118656C2 (en) | THE APPLICATION OF Bremelanotide in the Treatment of Female Sexual Dysfunction | |
| PH22011000489U3 (en) | Solid pharmaceutical herbal compositions | |
| UA68329U (en) | Method for luteinizing haemorrhagic follicles in mares | |
| EA201201498A1 (en) | MEANS FOR STRENGTHENING AND STIMULATING GROWTH OF HAIR |